Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 17 | 39 | 1 | 4 | 47 |
| Gross Profit | 17 | 39 | 1 | 4 | 47 |
| Operating Expenses | 45,582 | 39,037 | 39,498 | 40,556 | 28,602 |
| Operating Income | -45,565 | -38,998 | -39,497 | -40,552 | -28,555 |
| Other Income | 111 | 92 | 119 | 177 | 189 |
| Pre-tax Income | -45,454 | -38,906 | -39,378 | -40,375 | -28,366 |
| Net Income Continuous | -45,784 | -38,906 | -39,378 | -40,375 | -28,366 |
| Net Income | $-45,784 | $-38,906 | $-39,378 | $-40,375 | $-28,366 |
| EPS Basic Total Ops | -0.45 | -0.39 | -0.39 | -0.40 | -0.29 |
| EPS Basic Continuous Ops | -0.45 | -0.39 | -0.39 | -0.40 | -0.29 |
| EPS Diluted Total Ops | -0.45 | -0.39 | -0.39 | -0.40 | -0.29 |
| EPS Diluted Continuous Ops | -0.45 | -0.39 | -0.39 | -0.40 | -0.29 |
| EBITDA(a) | $-45,595 | $-39,668 | $-40,043 | $-40,719 | $-28,355 |